يعرض 1 - 10 نتائج من 63 نتيجة بحث عن '"Joneborg, Ulrika"', وقت الاستعلام: 0.98s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية

    المساهمون: Institute for Molecular Medicine Finland

    وصف الملف: application/pdf

    العلاقة: B.S.L. acknowledges the Swedish Research Council (2021-03420) and Ake Wibergs Stiftelse (M19-0271). OK acknowledges the Knut and Alice Wallenberg Foundation (KAW 2015.0291), and the Swedish Research Council (2017-06095). We acknowledge Tom Erkers for constructive criticism of the manuscript. BioRender was used for the schematic graphics. Rebecka Bergstroem and Johan Lindberg are acknowledged for panel-sequencing of the patient-derived models used in the manuscript. Lidia Moyano-Galceran and Okan Gultekin are acknowledged for collection of several of the patient samples.Open access funding provided by Karolinska Institute; Åkerlund , E , Gudoityte , G , Moussaud-Lamodiere , E , Lind , O , Bwanika , H C , Lehti , K , Salehi , S , Carlson , J , Wallin , E , Fernebro , J , Ostling , P , Kallioniemi , O , Joneborg , U & Seashore-Ludlow , B 2023 , ' The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients ' , npj precision oncology , vol. 7 , no. 1 , 111 . https://doi.org/10.1038/s41698-023-00463-zTest; http://hdl.handle.net/10138/567946Test; 04401bca-336c-4c1e-ac6d-5de8391b511e; 001096168300001

  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
  6. 6
    دورية أكاديمية
  7. 7
  8. 8
    دورية أكاديمية

    المساهمون: Research Program in Systems Oncology, Kaisa Irene Lehti / Principal Investigator, INDIVIDRUG - Individualized Drug Therapy, Sampsa Hautaniemi / Principal Investigator, Research Programs Unit, HUSLAB, Biosciences, Faculty Common Matters (Faculty of Medicine), Bioinformatics, Department of Biochemistry and Developmental Biology, Precision Cancer Pathology, Department of Pathology, Olli Mikael Carpen / Principal Investigator

    وصف الملف: application/pdf

    العلاقة: We thank Stephen J Weiss and Jaana Oikkonen for comments, Anastasiya Chernenko and Sinikka Kollanus for technical assistance. We also thank the University of Helsinki core facilities Biomedicum Imaging Unit (BIU), Genome Biology Unit (supported by HiLIFE and the Faculty of Medicine) and the Biomedicum Imaging Core (BIC) at Karolinska Institutet. This work was funded by Sigrid Juselius Foundation (to K.L., O.C.), Finnish Cancer Foundation (to K.L., E.A.P., O.C.), Orion Research Foundation (to E.A.P.), K. Albin Johanssons Foundation (to K.L., E.A.P.), Emil Aaltonen Foundation (to E.A.P.), KI Strategic Research Program in Cancer (StratCan-KICancer; to K.L.), Swedish Cancer Society (2015/723, 2018/858 to K.L., J.C.), Swedish Research Council (2019-01541 to K.L.), the European Union's Horizon 2020 research and innovation program under grant agreement No 667403 for HERCULES (to S. Hautaniemi, O.C., S.G.), and the Doctoral Programme in Integrative Life Science (to E.A.P.).; Pietilä , E A , Gonzalez-Molina , J , Moyano-Galceran , L , Jamalzadeh , S , Zhang , K , Lehtinen , L , Turunen , S P , Martins , T A , Gultekin , O , Lamminen , T , Kaipio , K , Joneborg , U , Hynninen , J , Hietanen , S , Grenman , S , Lehtonen , R , Hautaniemi , S , Carpen , O , Carlson , J W & Lehti , K 2021 , ' Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance ' , Nature Communications , vol. 12 , no. 1 , 3904 . https://doi.org/10.1038/s41467-021-24009-8Test; ORCID: /0000-0002-7749-2694/work/100256751; ORCID: /0000-0002-8343-0318/work/100257315; ORCID: /0000-0003-0209-9369/work/100258846; 014f7611-daf8-4b30-b75c-e6f5431f2169; http://hdl.handle.net/10138/334455Test; 000668769000003

  9. 9
    دورية أكاديمية

    المصدر: International Journal of Gynecologic Cancer ; volume 31, issue 3, page 399-411 ; ISSN 1048-891X 1525-1438

  10. 10
    دورية أكاديمية